BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun 2016;1:308-29. [PMID: 28217762 DOI: 10.20411/pai.v1i2.173] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Helleberg M, Cho D, Ekenberg C, Sørensen S, Rix M, Gustafsson F, Rasmussen A, Perch M, Andersen PHS, Lundgren JD, Andersen AB. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017. Tuberc Res Treat 2020;2020:7636975. [PMID: 32395341 DOI: 10.1155/2020/7636975] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Fraisse P. [Latent tuberculosis infection, from diagnosis to prognosis]. Rev Mal Respir 2018;35:785-7. [PMID: 30217572 DOI: 10.1016/j.rmr.2018.07.004] [Reference Citation Analysis]
3 Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study. Lancet Infect Dis 2021:S1473-3099(21)00145-6. [PMID: 34499863 DOI: 10.1016/S1473-3099(21)00145-6] [Reference Citation Analysis]
4 Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, Trebst C, Warnke C, Linker R, Kerschensteiner M, Zettl U, Tumani H, Brück W, Meuth SG, Kümpfel T, Hemmer B, Wiendl H, Gold R, Zipp F. [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Nervenarzt 2019;90:1245-53. [PMID: 31297574 DOI: 10.1007/s00115-019-0760-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Yang H, Park H. Factors influencing the initiation and adherence of LTBI treatment in healthcare workers: a systematic review. Arch Environ Occup Health 2021;:1-11. [PMID: 34184972 DOI: 10.1080/19338244.2021.1943642] [Reference Citation Analysis]
6 Sirbu CA, Dantes E, Plesa CF, Docu Axelerad A, Ghinescu MC. Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review. Medicina (Kaunas) 2020;56:E202. [PMID: 32344653 DOI: 10.3390/medicina56040202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Faust L, McCarthy A, Schreiber Y. Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries. BMC Public Health 2018;18:979. [PMID: 30081879 DOI: 10.1186/s12889-018-5886-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Muñoz L, Santin M, Alcaide F, Ruíz-Serrano MJ, Gijón P, Bermúdez E, Domínguez-Castellano A, Navarro MD, Ramírez E, Pérez-Escolano E, López-Prieto MD, Gutiérrez-Rodriguez J, Anibarro L, Calviño L, Trigo M, Cifuentes C, García-Gasalla M, Payeras A, Gasch O, Espasa M, Agüero R, Ferrer D, Casas X, González-Cuevas A, García-Zamalloa A, Bikuña E, Lecuona M, Galindo R, Ramírez-Lapausa M, Carrillo R; OPTIMIST Study Team. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial. Clin Infect Dis 2018;66:396-403. [PMID: 29020191 DOI: 10.1093/cid/cix745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lange C, Kalsdorf B, Maurer FP, Heyckendorf J. Tuberkulose. Internist 2019;60:1155-75. [DOI: 10.1007/s00108-019-00685-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
10 Sachsenweger J, Scheu KM, Lange C, Terhalle E. [35/f-Cervical lymphadenopathy : Preparation for the medical specialist examination: part 32]. Internist (Berl) 2021;62:245-50. [PMID: 33860807 DOI: 10.1007/s00108-021-00998-y] [Reference Citation Analysis]